IRX in epidermal differentiation
IRX in epidermal differentiation
批准号:
9973225
负责人:
Jefferson Chen
金额:
$4.55万
依托单位国家:
美国
项目类别:
财政年份:
2017
资助国家:
美国
项目状态:
已结题
起止时间:
2017-08-01 至 2022-07-31
关键词:
Atopic DermatitisBindingBinding SitesCell Adhesion MoleculesCell Fate ControlCellsChildClinicalComplexDefectDevelopmentDifferentiated GeneDiseaseEctodermEmbryoEnhancersEnzymesEpidermisEpigenetic ProcessExhibitsFamilyGene ActivationGene ExpressionGene Expression RegulationGenesHair follicle structureHealthHumanIn VitroIndividualInflammatoryKnockout MiceKnowledgeLeadLinkLipidsModelingMolecularMusNeuronsNewborn InfantNucleic Acid Regulatory SequencesPatternPermeabilityPhenotypePlayPremature InfantProcessPsoriasisRegulator GenesRoleSkinSkin AbnormalitiesSkin CancerStructural ProteinStructureTestingWorkXenopusexperimental studyhomeodomainhuman modelin vitro Modelinnovationinsightkeratinocytekeratinocyte differentiationknock-downneural platenovelpostnatalprogenitorrelating to nervous systemsegregationsingle cell analysisskin barrierskin disorderskin organogenesistranscription factortranscriptome
中文摘要
点击翻译按钮获取中文摘要
英文摘要
PROPOSAL SUMMARY
Epidermal differentiation is critical for health with differentiation defects underlying skin diseases in children,
including the common Atopic Dermatitis. Epidermal differentiation is a complex process in which enhancers,
epigenetic changes, and transcription factors coordinately regulate the expression of structural proteins,
adhesion molecules, and lipid producing enzymes necessary for epidermal barrier formation. Dramatic gene
expression changes observed in differentiation correspond to large-scale reorganization of epigenetic regulator
structures such as super-enhancers, which preferentially drive expression of genes vital for cell identity. In
recent experiments, we have studied the dynamics of enhancer formation during differentiation of human
keratinocytes. Within the super-enhancer encompassing the gene body of Grhl3, a key regulator of epidermal
differentiation, we identified enriched binding sites for IRX, a transcription factor with unknown roles in the
epidermis, suggesting that IRX may promote epidermal differentiation. Consistent with this idea, we found that
the temporal expression of several IRX factors in mouse epidermal development mirrors that of known
regulatory transcription factors for epidermal differentiation, including GRHL3. Depletion of GRHL3 in
keratinocytes changes the enhancer landscape with formation of new non-keratinocyte super-enhancers that
promote neuronal cell fate. Intriguingly, these newly formed enhancers exhibit striking overrepresentation of
IRX binding sites, suggesting that GRHL3 may suppress the tendency of keratinocytes to exhibit neuronal-type
features. The temporal expression pattern of several Irx genes in mouse epidermal development is similar to
that of well-known epidermal differentiation. Single cell analysis of newborn mice epidermis unveiled a gradient
of Irx3 expression that correlates with the keratinocyte's degree of differentiation. These preliminary results
suggest that IRX plays a key role in epidermal differentiation. The hypothesis is that an interplay between
GRHL3 and IRX promotes epidermal differentiation through at least two different mechanisms: 1) both IRX and
GRHL3 activate genes expressing epidermal differentiation factors, and 2) GRHL3 suppresses the formation of
IRX-sensitive SEs that otherwise would activate non-epidermal, neuronal genes in the differentiating
epidermis. Two Aims are proposed to test the hypothesis: Aim 1 will utilize an in vitro model of human
epidermal keratinocyte differentiation to provide insights into the mechanism whereby IRX regulates
differentiation. Aim 2 will utilize conditional Irx3;Irx5 double knockout mice to characterize the epidermal
differentiation phenotype of mice deficient for Irx3 and Irx5 in the epidermis. This work will establish the role of
IRX in skin development and elucidate how GRHL3 and IRX collaborate in epidermal differentiation.
期刊论文(0)
专著(0)
科研奖励(0)
会议论文
IRX in epidermal differentiation
-
批准号:10208914
-
项目类别:
-
资助金额:$5.1万
-
财政年份:2017
-
负责人:Jefferson Chen
-
依托单位:
国内基金
海外基金
登录
查看更多内容
帽结合蛋白(cap binding protein)调控乙烯信号转导的分子机制
-
批准号:32170319
-
项目类别:面上项目
-
资助金额:58.00万元
-
批准年份:2021
-
负责人:董春海
-
依托单位:
帽结合蛋白(cap binding protein)调控乙烯信号转导的分子机制
-
批准号:--
-
项目类别:--
-
资助金额:58万元
-
批准年份:2021
-
负责人:董春海
-
依托单位:
ID1 (Inhibitor of DNA binding 1) 在口蹄疫病毒感染中作用机制的研究
-
批准号:31672538
-
项目类别:面上项目
-
资助金额:62.0万元
-
批准年份:2016
-
负责人:孙跃峰
-
依托单位:
番茄EIN3-binding F-box蛋白2超表达诱导单性结实和果实成熟异常的机制研究
-
批准号:31372080
-
项目类别:面上项目
-
资助金额:80.0万元
-
批准年份:2013
-
负责人:杨迎伍
-
依托单位:
P53 binding protein 1 调控乳腺癌进展转移及化疗敏感性的机制研究
-
批准号:81172529
-
项目类别:面上项目
-
资助金额:58.0万元
-
批准年份:2011
-
负责人:杨其峰
-
依托单位:
DBP(Vitamin D Binding Protein)在多发性硬化中的作用和相关机制的蛋白质组学研究
-
批准号:81070952
-
项目类别:面上项目
-
资助金额:35.0万元
-
批准年份:2010
-
负责人:刘师莲
-
依托单位:
研究EB1(End-Binding protein 1)的癌基因特性及作用机制
-
批准号:30672361
-
项目类别:面上项目
-
资助金额:24.0万元
-
批准年份:2006
-
负责人:徐宁志
-
依托单位: